Apoptosis is a basic life phenomenon that exists widely in the biological world. It plays an important role in cell growth, development and proliferation. It is currently believed that extracellular stimuli that induce apoptosis must pass through a series of signal transmissions within the cell, which is one of the important markers for DNA-selective cleavage between nucleosomes. The term was first introduced in the 1970s to refer to a single cell mild death form controlled by genes under physiological or certain pathological conditions. In the process of occurrence and development of multicellular organisms, in order to maintain normal physiological functions, some cells undergo spontaneous cell death, which is regulated by a series of related molecules in the cell, accompanied by typical morphological changes. This phenomenon is called apoptosis. Apoptosis refers to the process in which a cell automatically ends its life under the control of an intrinsic genetic mechanism under certain physiological or pathological conditions. And programmed cell death (PCD) refers to the reactive death of a certain physiological stimulus during development, which requires certain gene expression. Apoptosis is a description of the morphological changes in a series of fixed patterns during cell death, while PCD is a functionally focused concept. There are differences between the two, but they are often mixed. Apoptosis (ap. Ptosis) or programmed cell death (PCD) is a cellular death process in which multicellular organisms regulate the development of the body and maintain the stability of the Pb gene. At present, there are various names for spontaneous degeneration of cells. More commonly used is programmed cell death (Pr08Nmmed celld6ath, PcD), originally used for embryonic development. The spontaneous degeneration of cells in specific parts during embryonic differentiation is caused by the expression of intracellular genes in this part according to certain procedures, also known as gene-scheduled cell death, physiological cell death, naturally occurring cell death, cell sequestration, apoptosis. Or apoptosis, etc. Apoptosis is characterized by nucleus condensation, chromosomal DNA being cut into ladders by nucleosomes, cell shrinkage, and finally formation of apoptotic bodies. Does not cause the dissolution of surrounding cells. Apoptosis is emitted in the cell population, progresses in stages, and depends on the supply of ATP and the synthesis of RNA and protein, which is an active elimination mechanism. It can be observed not only in the physiological state such as individual development and egg cell retreat, but also in many diseases and pathological conditions such as autoimmune diseases, neurodegenerative diseases, and ischemic diseases. The intracellular signaling pathway of apoptosis can be roughly divided into two phases, an induction phase and an implementation phase. Factors inducing apoptosis during the induction phase of apoptosis are endogenous and exogenous. Endogenous factors include the activation and inhibition mechanisms of apoptosis-inducing mechanisms (such as Fas ligand, tumor necrosis factor, etc.) (inhibition of growth factors, hormones, receptor factors and other proliferative factors). Exogenous factors include physical factors such as radiation and heat shock, chemical factors such as drugs and poisons, and biological factors such as viruses and bacteria. In recent years, it has also been found that the effects of reactive oxygen species and nitric oxide on nervous system diseases, cardiovascular diseases, immune diseases and aging are related to apoptosis to varying degrees. Recent studies have shown that the key link in the occurrence of apoptosis is not in the nucleus but in the cytoplasm. The mitochondrial membrane function changes, the intimal transmembrane potential disappears and the release of protease activators in the mitochondria induces various apoptosis-related metabolic changes before apoptotic cells are induced to undergo characteristic morphological changes and DNA degradation. Biological functions of apoptosis (1) Elimination of unwanted or redundant cells, the human brain has 95% of cell death during development. (2) Remove cells that are no longer functioning. The tail cells die when the sputum is abnormal; the mammalian endometrial epithelial cells die during the menstrual period. (3) Remove abnormally developed cells. As the development of the vertebrate visual system, neurons that do not form the correct neuronal connections are removed. (4) Some harmful cells are removed, and thymocytes are induced to die before leaving the thymus. The process of apoptosis The process of apoptosis can be roughly divided into four stages: (1) Apoptosis signal transduction When the apoptosis-inducing factors inside and outside the cell bind to the affected cell receptor, the cells produce complex biochemical reactions. And form a second messenger related to apoptosis: cAMP, Ca2+, ceramide and other signaling molecules form a death signal. (2) The apoptotic gene regulated by apoptotic gene activation starts to follow a predetermined program after receiving the death signal, and synthesizes various enzymes and related substances required for performing apoptosis. (3) Execution of apoptosis (common pathway) The main performers of apoptosis are two types of enzymes: endogenous nuclease (Dnase) - a biological command system that completely destroys cells; Caspases 3 - a complete disintegration of cells. (4) Clearance of apoptotic cells After apoptosis, cells can be decomposed by adjacent macrophages.


Amino compound >
Oxy-containing amino compound Cycloalkylamines, aromatic monoamines, aromatic polyamines and derivatives and salts thereof Acyclic monoamines, polyamines and their derivatives and salts Amide compound Sulfonic acid amino compound
Alcohols, phenols, phenolic compounds and derivatives >
2-cycloalcohol Halogenated, sulfonated, nitrated or nitrosated derivatives of alcohols Extremely halogenated, sulfonated, nitrated or nitrosated derivatives of phenols Phenol and its halogenated, sulfonated, nitrated or nitrosated derivatives Acyclic alcohol
Nitrogen-containing compound
Nitrile compound
Organic derivative of hydrazine or hydrazine
Terpenoid
Ether compounds and their derivatives >
Ether, ether alcohol Halogenation, sulfonation, nitration or nitrosation of ethers, ether alcohols, ether phenols
Aldehyde
Carboxylic compounds and derivatives >
Cyclic carboxylic acid Halogenation, sulfonation, nitration or nitrosation of carboxylic acids Halogenation, sulfonation, nitration or nitration of carboxylic anhydrides Carboxylic acid halide Carboxylic esters and their derivatives Salt of carboxylic acid ester and its derivatives Acyclic carboxylic acid
Hydrocarbon compounds and their derivatives >
Aromatic hydrocarbon Cyclic hydrocarbon Hydrocarbon sulfonate Hydrocarbon halide Hydrocarbon nitrite Acyclic hydrocarbon
Ketone compound
Alkyl ureas and their derivatives and salts
Inorganic acid ester
Heterocyclic compound
Diazo, azo or azo compound
Organosilicon compound
Organometallic compound >
Organic palladium Organic germanium, cobalt, strontium, barium, gallium, germanium, germanium, germanium, germanium, etc. Organic calcium Zirconium Organic potassium Organic Organic lithium Organic Organic aluminum Organotin Organic manganese Organic sodium Organic nickel Organic titanium Organic iron Organic copper Organotin Organic zinc Organic Organic Organic germanium, mercury, silver, platinum, etc. Organic germanium, antimony, bismuth, tungsten, antimony, bismuth, lead, vanadium, molybdenum, chromium, antimony, etc.
Organic sulfur compound
Organic phosphine compound
Organometallic salt
Organic fluorine compound >
Fluorobenzoic acid series Fluorobenzonitrile series Fluorobenzaldehyde series Fluorobenzyl alcohol series Fluoroanisole series Fluoroaniline series Fluorophenylacetic acid series Fluorophenol series Fluorobenzoic acid series Fluoronitrobenzene series Fluoropyridine series Potassium fluoroborate series Fluorobenzyl alcohol series Fluorotoluene series Fluorine red series Fluoroethane series Fluoropropane series
Respiratory medication >
Asthma Other respiratory medications Peony Antitussive
Hormone and endocrine-regulating drugs >
Birth control pills Pituitary hormone Estrogen and progestogen drugs Adrenocorticotropic drugs Gonadotropin Thyroid hormone and antithyroid drugs other Prostaglandins Adrenal corticosteroids Androgen and anabolic hormone drugs Pancreatic hormones and other blood sugar regulating drugs Treatment of male erectile dysfunction drugs
Antipyretic analgesics >
Non-steroidal anti-inflammatory drugs Antipyretic and analgesic Anti-migraine drug Anti-gout medicine Analgesic
Antiallergic >
Allergic reaction medium blocker Antihistamine
Antiparasitic drug >
Anti-amebiasis and anti-trichomoniasis drugs Antimalarial Resistance to filariasis and anti-leishmaniasis Anti-fungal medicine Anthelmintic Antiprotozoal Anthelmintic
Antibiotics >
Beta-lactamase inhibitor Aminoglycoside Macrolide drug Peptide Polyene Rifamycin Lincosamide Other antibiotics Penicillin Tetracycline Cephalosporin Amide alcohol Agricultural antibiotics
Antineoplastic agents >
Hormone antineoplastic agents Antimetabolite antineoplastic Antibiotic antineoplastic agents Anti-tumor adjuvant Other antineoplastic agents Natural source antineoplastic agents Alkylating agent Tinic antineoplastic agents Idiopathic pulmonary fibrosis (IPF) treatment
Anesthetic Agents >
Skeletal muscle relaxant Local anesthetics General anesthetics
Urinary system medication >
Diuretic Diabetes insipidus medication Other urinary system medication Dehydrated medicine
Other chemicals >
other Health and epidemic prevention drugs
Synthetic anti-infective drugs >
Sulfonamides and synergists Antiviral drugs Anti-tuberculosis leprosy Antihelium drug Antifungal drugs Quinolone Natural source anti-infectives Disinfectant antiseptic Nitrofuran
Nervous system medication >
2 sedative and hypnotics Antiepileptic and anticonvulsant Anxiolytic Antipsychotic Antidepressant, manic Anti-shock palsy Brain metabolism regulating drug Cholinergic Other nervous system medication Central stimulant Parkinson's syndrome
Water, electrolyte and acid-base balance regulator >
Electrolyte balance regulator Glucose drug Acid-base balance regulator
Vitamins and minerals >
Trace elements and mineral drugs Vitamin AD drugs Vitamin B drugs Vitamin C drugs Nutritional health medicine
Digestive system medication >
Liver disease medication Acid and gastric mucosal protective drugs Biliary medicine Other digestive system medication Appetite suppressant and other diet pills Gastrointestinal drug Gastrointestinal expectorant Laxative antidiarrheal Inhibition of gastric acid secretion Antiemetic emetic Digestive drug
Blood system medication >
Leukocyte proliferative drug Platelet proliferative drug Anticoagulant and antiplatelet drugs Anti-anemia drug Blood volume expander Hemostatic drug
Circulatory system medication >
Regulating blood lipids Prevention and treatment of angina pectoris Calcium channel blocker Anti-congestive heart failure medicine Antihypertensive drug Antiarrhythmic drug Anti-shock vasoactive drug Other circulatory system medication Angiotensin converting enzyme and receptor inhibitor Peripheral vasodilator Beta-adrenergic receptor blocker Treatment of chronic cardiac insufficiency Anti-atherosclerosis
Diagnostic medication >
Organ function test agent Image inspection medication
Special medicine >
Radioisotope Antidote Stomatology medication Dermatology medication Surgical medication Ophthalmic medication
Drugs that affect tissue metabolism
Feed drug additive
Anti-stress drug
Immune function drug >
Immunomodulatory drug Immunosuppressive drug
Veterinary drug raw materials
Inhibitor
Common amino acids and protein drugs
Nucleic acid drug
Enzymes and coenzymes
Inhibitor >
Immune inhibitor Protein tyrosine kinase Neuronal Signaling PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones G protein coupled receptor(GPCR & G Protein) Transmembrane Transporters Tyrosine protein kinase/signal transducer and transcriptional activator inhibitor (JAK/STAT) TGF-beta/Smad signaling pathway inhibitor (TGF-beta/Smad) Stem Cells & Wnt Signaling Paths (Stem Cells & Wnt) Nuclear transcription factor (NF-κB) Ubiquitin inhibitor Microbiology Autophagy lysosome (Autophagy)
Biological response modifier
Fatty drug
Amino acids and their derivatives >
Arginine derivatives Asparagine derivatives Aspartic acid derivative Cysteine derivative Glutamine derivative Glutamic acid derivative Glycine derivatives Histidine derivative Isoleucine derivative Leucine derivative Lysine derivative Methionine derivatives Phenylalanine derivatives Proline derivatives Serine derivative Threonine derivative Tryptophan derivatives Tyrosine derivatives Proline derivatives Alanine derivatives Methionine derivatives BOC-amino acid Cbz-amino acid FMOC-amino acid --amino acid Other protected amino acids Amino alcohol derivative Amino acid salt Ester amino acid Other amino acid derivatives Natural amino acids and their derivatives
Carbohydrate >
Monosaccharide Oligosaccharide Polysaccharide Double sugar
Biochemical reagent >
Biological dye Acid-base indicator Adjuvant
Nucleoside drugs >
Nucleoside intermediate Deoxynucleotides and their analogues Nucleotides and their analogues
Condensing agent
Peptide
Natural product
Plant extracts
Chinese herbal medicine ingredients
Microbiological reagent
Protein research
antibody >
Antibody Enzyme secondary antibody Apoptosis and autophagy Cell metabolism Chromatin / epigenetic / cell cycle Cytoskeleton/extracellular matrix MAPK and PI3K/Akt pathway Neuroscience Immunity and inflammation PKC, calcium ion and lipid signaling pathway Stem cells, development and differentiation Protein translation, folding and degradation Other categories of primary antibodies
  • CAS Number: 675576-97-3
  • MF: C30H30Cl2N4O4
  • MW: 581.490
  • Catalog:Mdm2 antagonist
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 518303-20-3
  • MF: C18H14BrNO5S2
  • MW: 468.341
  • Catalog:Bcl-2 inhibitor
  • Density: 1.79±0.1 g/cm3
  • Boiling Point: 661.2±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 353.7±34.3 °C
  • CAS Number: 675576-98-4
  • MF: C30H30Cl2N4O4
  • MW: 581.490
  • Catalog:Mdm2 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1597403-47-8
  • MF: C22H24Cl2N2O4
  • MW: 451.343
  • Catalog:PERK inhibitor
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 719.0±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 388.6±32.9 °C
  • CAS Number: 803712-79-0
  • MF: C21H23N3O4S
  • MW: 413.490
  • Catalog:Bcl-2 inhibitor
  • Density: N/A
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1257044-40-8
  • MF: C45H50ClN7O7S
  • MW: 868.439
  • Catalog:Bcl-2 inhibitor
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 380315-80-0
  • MF: C20H23N3O2S
  • MW: 369.480
  • Catalog:P53 activator
  • Density: 1.238±0.06 g/cm3 (20 ºC 760 Torr)
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 273404-37-8
  • MF: C24H33ClN4O6
  • MW: 508.995
  • Catalog:Caspase inhibitor
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 779.0±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 424.9±32.9 °C
  • CAS Number: 866541-93-7
  • MF: C32H34O10
  • MW: 578.60600
  • Catalog:Bcl-2 inhibitor
  • Density: N/A
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1337532-29-2
  • MF: C23H21FN6O
  • MW: 416.451
  • Catalog:PERK inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 744.6±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 404.1±32.9 °C
  • CAS Number: 781661-94-7
  • MF: C20H19BrN4O3
  • MW: 443.294
  • Catalog:Survivin inhibitor
  • Density: N/A
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 213261-59-7
  • MF: C14H12O3S2
  • MW: 292.373
  • Catalog:P53 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 464.9±40.0 °C at 760 mmHg
  • Melting Point: 160 °C
  • Flash Point: 235.0±27.3 °C
  • CAS Number: 1005342-46-0
  • MF: C26H33FN4O3S
  • MW: 500.629
  • Catalog:IAP inhibitor
  • Density: 1.2±0.1 g/cm3
  • Boiling Point: 713.7±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 385.4±32.9 °C
  • CAS Number: 58131-57-0
  • MF: C11H13N5O4
  • MW: 279.252
  • Catalog:Mdm2 activator
  • Density: 1.6±0.1 g/cm3
  • Boiling Point: 487.6±55.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 248.7±31.5 °C
  • CAS Number: 187389-52-2
  • MF: C22H30FN3O7
  • MW: 467.488
  • Catalog:Caspase inhibitor
  • Density: 1.2±0.1 g/cm3
  • Boiling Point: 732.4±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 396.7±32.9 °C
  • CAS Number: 890090-75-2
  • MF: C30H30Cl2N4O4
  • MW: 581.49
  • Catalog:Mdm2 antagonist
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1337531-36-8
  • MF: C24H20F3N5O
  • MW: 451.444
  • Catalog:PERK inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 720.3±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 389.4±32.9 °C
  • CAS Number: 210344-95-9
  • MF: C30H41FN4O12
  • MW: 668.664
  • Catalog:Caspase inhibitor
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 914.2±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 506.7±34.3 °C
  • CAS Number: 1229705-06-9
  • MF: C31H29Cl2F2N3O4
  • MW: 616.482
  • Catalog:Mdm2 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 737.3±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 399.7±32.9 °C
  • CAS Number: 852808-04-9
  • MF: C42H45ClN6O5S2
  • MW: 813.427
  • Catalog:Bcl-2 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: 152-154ºC
  • Flash Point: N/A
  • CAS Number: 1011557-82-6
  • MF: C25H34N4O2S
  • MW: 454.628
  • Catalog:P53 activator
  • Density: 1.2±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 64984-31-2
  • MF: C8H7NO2S
  • MW: 181.212
  • Catalog:P53 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 351.7±25.0 °C at 760 mmHg
  • Melting Point: 135.0 to 139.0 °C
  • Flash Point: 166.5±23.2 °C
  • CAS Number: 873652-48-3
  • MF: C25H34N6O3S
  • MW: 498.641
  • Catalog:IAP antagonist
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1001600-56-1
  • MF: C70H96N10O8
  • MW: 1205.57000
  • Catalog:IAP inhibitor
  • Density: N/A
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 1228108-65-3
  • MF: C42H40N2O8
  • MW: 700.776
  • Catalog:Bcl-2 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: 905.9±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 501.7±34.3 °C
  • CAS Number: 315183-21-2
  • MF: C23H28N4O2
  • MW: 392.494
  • Catalog:Caspase activator
  • Density: 1.1±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 405060-95-9
  • MF: C21H17Cl3N4OS
  • MW: 479.810
  • Catalog:PERK activator
  • Density: 1.5±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: N/A
  • Flash Point: N/A
  • CAS Number: 877877-35-5
  • MF: C33H35NO6S
  • MW: 573.699
  • Catalog:Bcl-2 inhibitor
  • Density: 1.3±0.1 g/cm3
  • Boiling Point: 723.7±60.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 391.5±32.9 °C
  • CAS Number: 923564-51-6
  • MF: C47H55ClF3N5O6S3
  • MW: 974.613
  • Catalog:Bcl-2 inhibitor
  • Density: 1.4±0.1 g/cm3
  • Boiling Point: N/A
  • Melting Point: 114-116ºC
  • Flash Point: N/A
  • CAS Number: 79183-19-0
  • MF: C15H9Cl2NO2
  • MW: 306.143
  • Catalog:Caspase activator
  • Density: 1.5±0.1 g/cm3
  • Boiling Point: 470.6±55.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 238.4±31.5 °C